Stay updated on Pembrolizumab vs Chemo for Advanced Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Chemo for Advanced Urothelial Cancer Clinical Trial page.

Latest updates to the Pembrolizumab vs Chemo for Advanced Urothelial Cancer Clinical Trial page
- Check4 days agoChange DetectedA site-wide banner announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check11 days agoChange DetectedThe footer’s site revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check18 days agoChange DetectedThe ClinicalTrials.gov page remains a 403 Forbidden error page, with its footer revision identifier updated from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check38 days agoChange DetectedThe study page now displays a 403 Forbidden error with a minimal header, indicating the page is inaccessible; the HTML snippet shows 403 and a 'Revision: v3.7.0' line.SummaryDifference20%

- Check59 days agoChange DetectedAdded 2014 ( U.S. NIH Grant/Contract ) note and updated the revision to v3.6.6; Removed Revision: v3.6.5.SummaryDifference0.1%

- Check80 days agoChange DetectedThe site revision was updated from v3.6.4 to v3.6.5, indicating an incremental platform update. This update does not alter the study content or visible information on the page.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab vs Chemo for Advanced Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Chemo for Advanced Urothelial Cancer Clinical Trial page.